Alterity Therapeutics Limited (ATHE)

Nasdaq: ATHE · Pharmaceutical Preparations · Melbourne, AU · filing with the SEC since 2002

Grade5.7

◀ Past 5.2● Present 5.3▶ Future 6.3

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In Australian dollars (AUD), as filed; per-share figures in Australian dollars; share counts. The fiscal year ends in June.

The Form 20-F filed Aug 28, 2026 for the period ended Jun 30, 2026 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Report filed	Aug 28, 2026	Aug 29, 2025	Sep 26, 2024	Aug 31, 2023	Aug 31, 2022	Sep 2, 2021	Sep 15, 2020	Aug 30, 2019	Aug 31, 2018	Aug 31, 2017
Revenue	·	·	·	·	·	·	·	·	201,174	132,396
Research and development	17,629,577	14,404,282	18,644,047	13,198,583	14,745,776	12,283,848	10,098,439	12,983,185	6,698,016	5,700,339
General and administrative	10,528,013	5,481,399	4,762,643	5,056,571	5,513,915	6,937,842	3,446,139	4,308,352	4,341,058	3,968,630
Finance costs	·	6,188	7,217	4,565	2,285	1,299	3,877	·	·	·
Interest income	1,716,656	446,291	268,419	16,436	2,504	20,676	17,117	108,538	201,174	132,396
Other gains and losses	90,123	-67,111	261,152	917,650	2,722,430	-297,111	·	·	·	·
Income before income taxes	-23,287,450	-12,079,773	-19,077,376	-13,702,056	-12,777,053	-15,309,353	-13,456,800	-12,337,830	-8,265,737	-7,542,076
Income tax expense	113,499	68,055	46,088	104,459	70,008	·	·	0	0	0
Net income	-23,400,949	-12,147,828	-19,123,464	-13,806,515	-12,847,061	-15,309,353	-13,456,800	-12,337,830	-8,265,737	-7,542,076
Net income to shareholders	·	·	·	13,806,515	12,847,061	15,309,353	13,456,800	12,337,830	·	·
Earnings per share, basic	-11.12	-9.50^r	-26.20^r	-0.57	-0.53	-0.90	-1.50	·	·	·
Earnings per share, diluted	·	-9.50^b	-26.00^b	-28.50^b	-26.50^b	-45.00^b	-75.00^b	-100.00^b	·	·
Earnings per share, basic and diluted	·	·	·	·	·	·	-75.00^b	-100.00^b	-77.50^b	-70.50^b
Weighted average shares, basic	210,494,323	127,938,483^r	72,977,512^r	48,556,838^b	48,119,801^b	33,937,526^b	17,897,444^b	12,315,445^b	10,677,829^b	10,677,829^b
Weighted average shares, diluted	·	127,938,482^b	72,977,511^b	48,556,838^b	48,119,801^b	33,937,526^b	17,897,444^b	·	·	·

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-50 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:Revenue

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense

Finance costs what its borrowing costifrs-full:InterestExpense

Interest income what its cash and investments earnedifrs-full:RevenueFromInterest

Other gains and losses gains and costs outside the businessifrs-full:OtherGainsLosses

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Earnings per share, basic and diluted net income per share, where both counts are the sameifrs-full:BasicAndDilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton ATHE · research, not advice